Back to Search
AHMED AHMED, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1124721865Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
PMID 17065638·N Engl J Med·2006
3-trial
Use of intravenous immunoglobulin therapy in autoimmune blistering diseases.
PMID 16504919·Int Immunopharmacol·2006
6-review
Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy.
PMID 15268639·Expert Opin Investig Drugs·2004
6-review
Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases.
PMID 12925395·Arch Dermatol·2003
6-review
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions.
PMID 12878746·N Engl J Med·2003
5-case
Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy.
PMID 11756944·J Am Acad Dermatol·2002
8-other
Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
PMID 11606916·J Am Acad Dermatol·2001
3-trial
Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
PMID 11712025·J Am Acad Dermatol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (617) 732-5775
Quick Facts
- NPI
- 1124721865
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile